Nextech Invest Ltd. 13F holdings
Nextech Invest Ltd. reported 15 positions with a total reported value of $2.1B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: RVMD REVOLUTION MEDICINES INC (67.6%), PBLS PARABILIS MEDICINES INC (6.1%), RLAY RELAY THERAPEUTICS INC (6.0%), TYRA TYRA BIOSCIENCES INC (5.4%), ALMS ALUMIS INC (4.7%). Against 2026-03-31 it opened 1 new position and exited 3. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Nextech Invest Ltd. files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
15 largest of 15 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| RVMD REVOLUTION MEDICINES INC | 7,601,087 | $1.4B | 67.6% |
| PBLS PARABILIS MEDICINES INC | 4,663,176 | $127.6M | 6.1% |
| RLAY RELAY THERAPEUTICS INC | 6,776,506 | $126.8M | 6.0% |
| TYRA TYRA BIOSCIENCES INC | 3,553,585 | $113.5M | 5.4% |
| ALMS ALUMIS INC | 3,540,998 | $99.6M | 4.7% |
| ORIC ORIC PHARMACEUTICALS INC | 7,162,637 | $77.6M | 3.7% |
| KYMR KYMERA THERAPEUTICS INC | 278,896 | $32.0M | 1.5% |
| ZYME ZYMEWORKS INC | 1,113,946 | $29.1M | 1.4% |
| GLUE MONTE ROSA THERAPEUTICS INC | 761,153 | $18.4M | 0.9% |
| ARVN ARVINAS INC | 1,122,713 | $17.1M | 0.8% |
| CTMX CYTOMX THERAPEUTICS INC. | 4,449,932 | $16.7M | 0.8% |
| SLN SILENCE THERAPEUTICS PLC | 952,400 | $10.5M | 0.5% |
| CRVS CORVUS PHARMACEUTICALS INC | 450,000 | $6.7M | 0.3% |
| CNTX CONTEXT THERAPEUTICS INC | 7,419,355 | $4.1M | 0.2% |
| ENGN ENGENE THERAPEUTICS INC | 2,324,943 | $4.0M | 0.2% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| PBLS PARABILIS MEDICINES INC | 4,663,176 | $127.6M | 6.1% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 3 in all · reported value as of 2026-03-31
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| RLAY RELAY THERAPEUTICS INC | 5,526,506 | 6,776,506 | +22.6% | $126.8M |
| GLUE MONTE ROSA THERAPEUTICS INC | 304,237 | 761,153 | +150.2% | $18.4M |
| ARVN ARVINAS INC | 539,394 | 1,122,713 | +108.1% | $17.1M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| TYRA TYRA BIOSCIENCES INC | 4,055,861 | 3,553,585 | -12.4% | $113.5M |
CIK 1595430 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
